Variant report
Variant | nsv1026209 |
---|---|
Chromosome Location | chr7:53328721-53354464 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28588466 | chr7:53339462-53339463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139575562 | chr7:53339467-53339468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34907890 | chr7:53339591-53339592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566213951 | chr7:53339612-53339613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11506089 | chr7:53339632-53339633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs533292226 | chr7:53339651-53339652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555049081 | chr7:53339679-53339680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551781754 | chr7:53339684-53339685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34525577 | chr7:53339685-53339686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190596092 | chr7:53339690-53339691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397722784 | chr7:53339693-53339694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568354512 | chr7:53339703-53339704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56345811 | chr7:53339727-53339728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556980493 | chr7:53339732-53339733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182888060 | chr7:53339796-53339797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563562756 | chr7:53339809-53339810 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149913695 | chr7:53339817-53339818 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545696571 | chr7:53339824-53339825 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566909899 | chr7:53339842-53339843 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187735166 | chr7:53339873-53339874 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191406750 | chr7:53339922-53339923 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549303582 | chr7:53339940-53339941 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10250277 | chr7:53339971-53339972 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs144989449 | chr7:53339990-53339991 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544146616 | chr7:53340014-53340015 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149097996 | chr7:53340018-53340019 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182624717 | chr7:53340068-53340069 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552833993 | chr7:53340078-53340079 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10235222 | chr7:53340116-53340117 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs528638146 | chr7:53340117-53340118 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538390391 | chr7:53340206-53340207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143181264 | chr7:53340224-53340225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537074692 | chr7:53340225-53340226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571710376 | chr7:53340268-53340269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546350300 | chr7:53340285-53340286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557291054 | chr7:53340295-53340296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570686903 | chr7:53340328-53340329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146759604 | chr7:53340329-53340330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10253923 | chr7:53340367-53340368 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs10253927 | chr7:53340372-53340373 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs541584090 | chr7:53340373-53340374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555172525 | chr7:53340386-53340387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187303879 | chr7:53340404-53340405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544767519 | chr7:53340412-53340413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10253944 | chr7:53340426-53340427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564089050 | chr7:53340434-53340435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577515562 | chr7:53340512-53340513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562972784 | chr7:53340516-53340517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546509585 | chr7:53340571-53340572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533453855 | chr7:53340603-53340604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Biliary cancer | 19435499 | CNVD |
Wilms tumour | 21544195 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 22495311 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastric cancer | 24379144 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Ovarian cancer | 18182111 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Barrett''s esophagus | 18559552 | CNVD |
head and neck squamous cell carcinoma | 16943533 | CNVD |
Anaplastic thyroid cancer | 17079354 | CNVD |
Basal-like breast cancer | 17875215 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Colorectal cancer | 18794099 | CNVD |
Gastrointestinal stromal cancer | 17643098 | CNVD |
Lung cancer | 18381415 | CNVD |
Metastatic colorectal cancer | 17664472 | CNVD |
Non-small cell lung cancer | 19255323 | CNVD |
Non-small cell lung cancer | 17673923 | CNVD |
Non-small cell lung cancer | 17975165 | CNVD |
Non-small cell lung cancer | 19622585 | CNVD |
Ovarian cancer | 16607561 | CNVD |
Squamous cell cancer | 19670535 | CNVD |
head and neck squamous cell carcinoma | 16818711 | CNVD |
small cell lung cancer | 18829487 | CNVD |
Breast cancer | 17661082 | CNVD |
Adenocarcinoma | 19260752 | CNVD |
Esophageal cancer | 16575012 | CNVD |
Lung adenocarcinoma | 19138956 | CNVD |
Lung adenocarcinoma | 18379350 | CNVD |
Lung adenocarcinoma | 18258923 | CNVD |
Lung cancer | 19138956 | CNVD |
Lung cancer | 18379350 | CNVD |
Lung cancer | 18258923 | CNVD |
Non-small cell lung cancer | 18304967 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 19260752 | CNVD |
Non-small cell lung cancer | 17079354 | CNVD |
Non-small cell lung cancer | 18559607 | CNVD |
Rectal cancer | 19506820 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
head and neck squamous cell carcinoma | 18813952 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Non-small cell lung cancer | 16943533 | CNVD |
Non-small cell lung cancer | 18509184 | CNVD |
head and neck squamous cell carcinoma | 17538160 | CNVD |
Colorectal cancer | 19712476 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19671679 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21990379 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:53339400-53339800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:53339400-53341400 | Enhancers | Fetal Heart | heart |
3 | chr7:53339600-53339800 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr7:53339600-53340200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr7:53339800-53340000 | Enhancers | Right Atrium | heart |
6 | chr7:53339800-53340200 | Flanking Active TSS | Colon Smooth Muscle | Colon |
7 | chr7:53339800-53340600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr7:53339800-53341000 | Enhancers | Brain Angular Gyrus | brain |
9 | chr7:53339800-53341000 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr7:53340200-53341200 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr7:53340200-53341400 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr7:53340600-53341000 | Enhancers | Brain Germinal Matrix | brain |
13 | chr7:53340600-53341000 | Enhancers | Fetal Brain Female | brain |
14 | chr7:53340600-53341200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr7:53341000-53341400 | Enhancers | Brain Inferior Temporal Lobe | brain |
16 | chr7:53341200-53342600 | Weak transcription | Colon Smooth Muscle | Colon |
17 | chr7:53345200-53348400 | Weak transcription | Colon Smooth Muscle | Colon |
18 | chr7:53348000-53348600 | Enhancers | Rectal Smooth Muscle | rectum |
19 | chr7:53348400-53348800 | Enhancers | Colon Smooth Muscle | Colon |
20 | chr7:53349000-53349400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |